NEUROTHERAPEUTICS LTD
Executive Summary
Neurotherapeutics Ltd is a technology-driven medical equipment manufacturer strategically positioned within the electrotherapeutic device niche. Its strong academic and management leadership, supported by recent capital injections, provides a solid foundation to advance product development and commercialization. However, the company must carefully manage its cash burn, navigate regulatory hurdles, and build operational capacity to capitalize on growth opportunities and mitigate competitive and market risks.
View Full Analysis Report →Company Documents
| Date | Description |
|---|---|
| 23/07/2523 July 2025 New | Total exemption full accounts made up to 2024-12-31 |
| 22/05/2522 May 2025 | Statement of capital following an allotment of shares on 2025-05-16 |
| 18/02/2518 February 2025 | Confirmation statement made on 2025-02-10 with updates |
| 31/12/2431 December 2024 | Annual accounts for year ending 31 Dec 2024 |
| 07/11/247 November 2024 | Statement of capital following an allotment of shares on 2024-10-09 |
| 01/10/241 October 2024 | Appointment of Mr David John O'reilly as a director on 2024-09-01 |
| 30/09/2430 September 2024 | Appointment of Mr Karl Moss as a director on 2024-09-01 |
| 26/07/2426 July 2024 | Memorandum and Articles of Association |
| 26/07/2426 July 2024 | Resolutions |
| 24/07/2424 July 2024 | Statement of capital following an allotment of shares on 2024-07-23 |
| 16/07/2416 July 2024 | Second filing of a statement of capital following an allotment of shares on 2024-03-21 |
| 16/07/2416 July 2024 | Second filing of a statement of capital following an allotment of shares on 2024-03-18 |
| 16/07/2416 July 2024 | Second filing of a statement of capital following an allotment of shares on 2024-06-20 |
| 26/06/2426 June 2024 | Statement of capital following an allotment of shares on 2024-06-20 |
| 04/06/244 June 2024 | Statement of capital following an allotment of shares on 2024-03-18 |
| 16/05/2416 May 2024 | Total exemption full accounts made up to 2023-12-31 |
| 28/03/2428 March 2024 | Statement of capital following an allotment of shares on 2024-03-21 |
| 08/03/248 March 2024 | Confirmation statement made on 2024-02-10 with updates |
| 04/03/244 March 2024 | Change of share class name or designation |
| 03/03/243 March 2024 | Memorandum and Articles of Association |
| 03/03/243 March 2024 | Resolutions |
| 03/03/243 March 2024 | Resolutions |
| 03/03/243 March 2024 | Resolutions |
| 03/03/243 March 2024 | Resolutions |
| 03/03/243 March 2024 | Resolutions |
| 01/03/241 March 2024 | Termination of appointment of Stephen Raymond Jackson as a director on 2024-02-28 |
| 01/03/241 March 2024 | Termination of appointment of James Stuart Duncan as a director on 2024-02-21 |
| 29/02/2429 February 2024 | Appointment of Andrew Mcneill as a director on 2024-02-08 |
| 28/02/2428 February 2024 | Statement of capital following an allotment of shares on 2024-02-08 |
| 10/01/2410 January 2024 | Change of share class name or designation |
| 31/12/2331 December 2023 | Annual accounts for year ending 31 Dec 2023 |
| 07/06/237 June 2023 | Total exemption full accounts made up to 2022-12-31 |
| 17/05/2317 May 2023 | Statement of capital following an allotment of shares on 2023-02-14 |
| 10/02/2310 February 2023 | Confirmation statement made on 2023-02-10 with no updates |
| 09/02/239 February 2023 | Director's details changed for Dr Barbara Morera Maiquez on 2023-02-01 |
| 31/01/2331 January 2023 | Appointment of Mr Paul Michael Cable as a director on 2023-01-31 |
| 31/12/2231 December 2022 | Annual accounts for year ending 31 Dec 2022 |
| 06/12/226 December 2022 | Appointment of Dr Barbara Morera Maiquez as a director on 2022-12-01 |
| 28/01/2228 January 2022 | Notification of a person with significant control statement |
| 28/01/2228 January 2022 | Cessation of Barbara Morera Maiquez as a person with significant control on 2021-08-05 |
| 28/01/2228 January 2022 | Cessation of Stephen Raymond Jackson as a person with significant control on 2021-08-05 |
| 28/01/2228 January 2022 | Cessation of Georgina Margaret Jackson as a person with significant control on 2021-08-05 |
| 31/12/2131 December 2021 | Annual accounts for year ending 31 Dec 2021 |
| 07/10/217 October 2021 | Certificate of change of name |
| 10/08/2110 August 2021 | Current accounting period shortened from 2022-02-28 to 2021-12-31 |
| 29/07/2129 July 2021 | Resolutions |
| 29/07/2129 July 2021 | Resolutions |
| 29/07/2129 July 2021 | Resolutions |
| 20/07/2120 July 2021 | Appointment of James Stuart Duncan as a director on 2021-05-05 |
| 15/07/2115 July 2021 | Statement of capital following an allotment of shares on 2021-07-13 |
| 12/02/2112 February 2021 | CERTIFICATE OF INCORPORATION GENERAL COMPANY DETAILS & STATEMENTS OF; OFFICERS, CAPITAL & SHAREHOLDINGS, GUARANTEE, COMPLIANCE MEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company